Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 21, 2014; 20(31): 10851-10863
Published online Aug 21, 2014. doi: 10.3748/wjg.v20.i31.10851
Published online Aug 21, 2014. doi: 10.3748/wjg.v20.i31.10851
Figure 1 Serum biomarkers of disease activity may measure inflammation, apoptosis, oxidative stress or fibrosis.
This is a schematic representation of the pathophysiological processes in nonalcoholic fatty liver disease (NAFLD), markers of which may be demonstrable in serum. LDL: Low density lipoprotein; IL: Interleukin; TBARS: Thiobarbituric acid reactive substances; TIMP1: Tissue inhibitor of MMP 1.
- Citation: Fitzpatrick E, Dhawan A. Noninvasive biomarkers in non-alcoholic fatty liver disease: Current status and a glimpse of the future. World J Gastroenterol 2014; 20(31): 10851-10863
- URL: https://www.wjgnet.com/1007-9327/full/v20/i31/10851.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i31.10851